| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 08/06/2008 | EP1951744A2 A polypeptide molecular switch |
| 08/06/2008 | EP1581645B1 Method for using division arrested cells in screening assays |
| 08/06/2008 | EP1508047B1 Method for identifying immunoreactive peptides |
| 08/06/2008 | EP1015884B1 Methods of identifying molecules that home to angiogenic vasculature in tumors |
| 08/06/2008 | EP1005274B1 Orally active fraction of momordica charantia, active peptides thereof, and their use in the treatment of diabetes |
| 08/06/2008 | CN101238142A Polyoxyalkylene chain-containing lipid derivative and lipid film structure containing such derivative |
| 08/06/2008 | CN101237892A Method of conjugating aminothiol containing molecules to vehicles |
| 08/06/2008 | CN101235081A Method for preparing oxytocin |
| 08/06/2008 | CN101235080A Synthesis method of daptomycin |
| 08/06/2008 | CN101235079A Short peptide for inhibiting growing of liver cancer cell and application thereof |
| 08/06/2008 | CN100408683C HLA-A24-restricted cancer antigen peptide |
| 08/06/2008 | CN100408595C SARS virus HLA-A2 limited epitope polypeptide and uses thereof |
| 08/05/2008 | US7408030 Peptide that binds to the Fc region of an antibody; from liquid containing immunoglobulins such as blood or blood plasma, plasma fractions, ascites fluid, aqueous cell culture, milk, and colostrums |
| 08/05/2008 | US7408028 Peptides, antibodies thereto, and their use in treatment of central nervous system, damage |
| 08/05/2008 | US7408025 Bactericides; peptide antibiotic |
| 08/05/2008 | US7408024 Somatostatin antagonists |
| 08/05/2008 | US7408021 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 08/05/2008 | US7407940 Antimicrobial hexapeptides |
| 08/05/2008 | US7407939 Protein kinase inhibitors comprising ATP mimetics conjugated to peptides or peptidomimetics |
| 08/05/2008 | US7407661 Methods and reagents that generate a CD8 T cell immune response |
| 08/05/2008 | CA2167087C Peptides for neutralizing the toxicity of lipid a |
| 07/31/2008 | WO2008091246A1 Self-assembling amphiphilic polymers as antiviral agents |
| 07/31/2008 | WO2008089569A1 Papaya mosaic virus-based vaccines against salmonella typhi and other enterobacterial pathogens |
| 07/31/2008 | US20080182971 1-pyreneacetic acid, 1-pyrenemethylamine, 5(6)-carboxyfluorescein, EDTA, cyclam tetraacetic acid, lauric acid, cholesterol, D-biotin, carboxymethyl- beta -cyclodextrin, cysteine to form a peptide derivative; expose peptide derivative to silicon precursor; patterned by ink jet printing |
| 07/31/2008 | US20080182797 Short peptides comprising the amino acid sequence Cys-Glu-Phe-His as well as analogs and derivatives thereof, which peptides efficiently denitrate cellular proteins and thus prevent tissue damage associated with excess nitric oxide and its reactive species; protection against ischemia/reperfusion injury |
| 07/31/2008 | US20080182796 Modified Cry3A toxins and nucleic acid sequences coding therefor |
| 07/31/2008 | US20080182795 Specific antagonists for glucose-depenent insulinotropic polypeptide (GIP) |
| 07/31/2008 | US20080182788 Compositions and Methods for Increasing Bone Mineralization |
| 07/31/2008 | US20080182781 Process for the Preparation of Peptides |
| 07/31/2008 | CA2676481A1 Papaya mosaic virus-based vaccines against salmonella typhi and other enterobacterial pathogens |
| 07/31/2008 | CA2676239A1 Self-assembling amphiphilic polymers as antiviral agents |
| 07/30/2008 | EP1950294A1 Novel cell penetrating peptide |
| 07/30/2008 | EP1950224A2 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 07/30/2008 | EP1950223A2 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 07/30/2008 | EP1949936A2 Controlled release composition and method of producing the same |
| 07/30/2008 | EP1366078B1 Ige receptor antagonists |
| 07/30/2008 | EP1355920B1 Extractive purification of lipopeptide antibiotics |
| 07/30/2008 | EP1214448B1 A rapid quantitative measurement of soluble fibrin in opaque body fluids |
| 07/30/2008 | EP1179537B1 Solid phase peptide synthesis method |
| 07/30/2008 | EP0776209B1 Polynucleic acids and proteins from a porcine reproductive and respiratory syndrome virus and uses thereof |
| 07/30/2008 | EP0659276B2 Immunoassay for detecting collagen or collagen fragments |
| 07/30/2008 | CN101233150A Coloring compositions with peptide-based dispersants and binders |
| 07/30/2008 | CN101233149A Complement C3a derived peptides and uses thereof |
| 07/30/2008 | CN101233148A Macrocyclic peptides as HCV NS3 protease inhibitors |
| 07/30/2008 | CN101232896A Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure |
| 07/30/2008 | CN101230096A Peptide derived from hepatitis C virus |
| 07/30/2008 | CN101230095A Polypeptide organic compound and use thereof in hetero transplantation |
| 07/30/2008 | CN101230094A Polypeptide organic compound and use thereof in hetero transplantation |
| 07/30/2008 | CN101230093A Polypeptide organic compound and use thereof in hetero transplantation |
| 07/30/2008 | CN101230092A Polypeptide organic compound and use thereof in hetero transplantation |
| 07/30/2008 | CN101230091A Polypeptide organic compound and use thereof in hetero transplantation |
| 07/30/2008 | CN101230090A Blood peptide X and derivative thereof as well as preparation method and use thereof |
| 07/30/2008 | CN101229363A Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension |
| 07/30/2008 | CN100406468C Design of antisuppository KGD-cyclohepta-peptide, its preparation and use thereof |
| 07/29/2008 | US7405320 Therapeutic and diagnostic conjugates for use with multispecific antibodies |
| 07/29/2008 | US7405203 Pharmaceutical compositions including low dosages of desmopressin |
| 07/29/2008 | US7405201 Antibacterial macrocycles |
| 07/29/2008 | US7405200 Use of oxytocin for the preparation of a pharmaceutical composition against cancer in situ and cervicitis |
| 07/29/2008 | US7405198 Glycopegylated erythropoietin |
| 07/29/2008 | US7405038 Baculovirus expressing recombinant protein with gene inhibiting apoptosis |
| 07/29/2008 | US7404954 Drug delivery using Polymeric immunoglobulin receptor (pIgR) which when cleaved has a stalk region which remains attached to the cell and a secretory component (SC) which exists in an organ of interest in several forms |
| 07/29/2008 | US7404948 Peptidic conjugates for alopecia prevention and treatment |
| 07/29/2008 | CA2373680C Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components |
| 07/29/2008 | CA2305597C Affinity markers for human serum albumin |
| 07/29/2008 | CA2285673C Cyclic analogs of histatins |
| 07/29/2008 | CA2261835C Long-acting drugs and pharmaceutical compositions comprising them |
| 07/29/2008 | CA2160121C T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
| 07/24/2008 | WO2008088594A2 Isolation of antibodies that cross-react and neutralize rankl orginating from multiple species |
| 07/24/2008 | WO2008088583A2 Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer |
| 07/24/2008 | WO2008088548A2 Disintegrin variants and pharmaceutical uses thereof |
| 07/24/2008 | WO2008088385A2 Peptides that enhance acetylcholinesterase expression |
| 07/24/2008 | WO2008088331A1 Methods for increasing levels of human fetal hemoglobin |
| 07/24/2008 | WO2008086813A2 Peptides derived from proteins of the insulin super-family |
| 07/24/2008 | WO2008057463A3 Peptide-based conditioners |
| 07/24/2008 | WO2008045238A3 Stabilized therapeutic small helical antiviral peptides |
| 07/24/2008 | WO2007149542A3 Antimicrobial kinocidin compositions and methods of use |
| 07/24/2008 | WO2007089793A3 Tat-041 and methods of assessing and treating cancer |
| 07/24/2008 | WO2006096207A3 Methods for preparing multivalent constructs for therapeutic and diagnostic applications |
| 07/24/2008 | US20080177037 Leucine-based motif and clostridial neurotoxins |
| 07/24/2008 | US20080177036 Selective Linear Peptides with Melanocortin-4 Receptor (MC4-R) Agonist Activity |
| 07/24/2008 | US20080177035 making side group protected homocysteine by reacting methionine with sodium in ammonia then alkylating the mercapto group such as with tert-butoxycarbonylalkyl protecting group; use as intermediate in synthesis cyclic peptides, particularly oxytocin antagonist peptides |
| 07/24/2008 | US20080177034 Taspase1 and Methods of Use |
| 07/24/2008 | US20080177033 Self-Assembly of Peptide-Amphiphile Nanofibers under Physiological Conditions |
| 07/24/2008 | US20080176806 Therapeutic uses of tri-, tetra-, penta-, and polypeptides |
| 07/24/2008 | US20080176805 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/24/2008 | US20080176792 Vegfr-1 targeting peptides |
| 07/24/2008 | US20080176790 mutants of fibroblast growth factors containing N-linked or O-linked glycosylation sites ;drug-polymer conjugates, used for treating fibroblast growth factor deficiency in patients |
| 07/24/2008 | US20080176288 Colony stimulating factor fusion protein comprising polyanionic polymer for use tool to enhance drug delivery |
| 07/24/2008 | US20080176268 MN Gene and Protein |
| 07/24/2008 | US20080176249 GFP-SNAP25 Fluorescence Release Assay for Botulinum Toxin Protease Activity |
| 07/24/2008 | US20080176243 Designing vector system comprising regulatory sequences which utilize human chorionic gonadotropin and/or nuclear factor kappaB as modulators of genic expression |
| 07/24/2008 | US20080175855 Containing one or more epitopes recognized by and binding to a BAT monoclonal antibody; cancer vaccines |
| 07/24/2008 | CA2675753A1 Substance p and analogs thereof as an immunogenic composition adjuvant |
| 07/23/2008 | EP1947111A1 Novel mucin glycoprotein and use thereof |
| 07/23/2008 | EP1947109A2 Biologically active peptides |
| 07/23/2008 | EP1946109A1 Method for detecting autoantibodies formed in rheumatoid arthritis |
| 07/23/2008 | EP1608982B9 Diagnosis of autism |
| 07/23/2008 | CN101228182A Antibakterielle amid-makrozyklen v |
| 07/23/2008 | CN101225604A Coated fabric containing antibiotic peptides and preparation method thereof |
| 07/23/2008 | CN101225108A Human vascular endothelial growth factor receptor 3 binding peptide and screening method thereof |